Hydroxyurea for secondary stroke prevention in SCD, mutant CALR as a rogue cytokine in MPNs, and parsing pathobiology in Burkitt lymphoma
This episode reviews hydroxyurea's effectiveness in stroke prevention for sickle cell anemia patients in resource-limited settings. It also discusses how secreted mutant calreticulin acts as a rogue cytokine in MPNs and explores new findings on Burkitt lymphoma pathobiology…